Healthcare Analytics Market by Application (Financial Analysis, Operational & Administrative Analysis and Clinical Analysis), Component (Hardware, Software and Services), Deployment Model (On-Premise and On-Demand), End User (Healthcare Payers, Healthcare Providers and Others), and Type (Descriptive Analytics, Predictive Analytics, and Prescriptive Analytics): Global Opportunity Analysis and Industry Forecast, 2021–2030

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings

2.1.1.Top impacting factors

2.1.2.Top investment pockets

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key forces shaping the global Healthcare analytics market

3.3.Market dynamics

3.3.1.Drivers

3.3.1.1.Rise in adoption of big data in healthcare organizations

3.3.1.2.Growing government initiatives to increase the adoption of electronic health records (EHRs) among healthcare organizations

3.3.1.3.Pressure among the healthcare organizations to curb the unnecessary expensive

3.3.2.Restraints

3.3.2.1.High Implementation cost

3.3.2.2.Lack of skilled labors

3.3.3.Opportunities

3.3.3.1.Use of cloud-based analytics across various healthcare providers

3.4.COVID-19 impact analysis on healthcare analytics market

3.4.1.Impact on market size

3.4.2.Consumer trends, preferences, and budget impact

3.4.3.Economic impact

3.4.4.Strategies to tackle negative impact

3.4.5.Opportunity window

CHAPTER 4:HEALTHCARE ANALYTICS MARKET, BY APPLICATION

4.1.Overview

4.2.Financial Analysis

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.3.Operational & Administrative Analysis

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market analysis, by country

4.4.Clinical Analysis

4.4.1.Key market trends, growth factors, and opportunities

4.4.2.Market size and forecast, by region

4.4.3.Market analysis, by country

CHAPTER 5:HEALTHCARE ANALYTICS MARKET, BY COMPONENT

5.1.Overview

5.2.Hardware

5.2.1.Key market trends, growth factors, and opportunities

5.2.2.Market size and forecast, by region

5.2.3.Market analysis, by country

5.3.Software

5.3.1.Key market trends, growth factors, and opportunities

5.3.2.Market size and forecast, by region

5.3.3.Market analysis, by country

5.4.Service

5.4.1.Key market trends, growth factors, and opportunities

5.4.2.Market size and forecast, by region

5.4.3.Market analysis, by country

CHAPTER 6:HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL

6.1.Overview

6.2.On-premise

6.2.1.Key market trends, growth factors, and opportunities

6.2.2.Market size and forecast, by region

6.2.3.Market analysis, by country

6.3.On-Demand

6.3.1.Key market trends, growth factors, and opportunities

6.3.2.Market size and forecast, by region

6.3.3.Market analysis, by country

CHAPTER 7:HEALTHCARE ANALYTICS MARKET, BY END USER

7.1.Overview

7.2.Healthcare Payers

7.2.1.Key market trends, growth factors, and opportunities

7.2.2.Market size and forecast, by region

7.2.3.Market analysis, by country

7.3.Healthcare Providers

7.3.1.Key market trends, growth factors, and opportunities

7.3.2.Market size and forecast, by region

7.3.3.Market analysis, by country

7.4.Others

7.4.1.Key market trends, growth factors, and opportunities

7.4.2.Market size and forecast, by region

7.4.3.Market analysis, by country

CHAPTER 8:HEALTHCARE ANALYTICS MARKET, BY TYPE

8.1.Overview

8.2.Descriptive Analytics

8.2.1.Key market trends, growth factors, and opportunities

8.2.2.Market size and forecast, by region

8.2.3.Market analysis, by country

8.3.Predictive Analytics

8.3.1.Key market trends, growth factors, and opportunities

8.3.2.Market size and forecast, by region

8.3.3.Market analysis, by country

8.4.Prescriptive Analytics

8.4.1.Key market trends, growth factors, and opportunities

8.4.2.Market size and forecast, by region

8.4.3.Market analysis, by country

CHAPTER 9:HEALTHCARE ANALYTICS MARKET, BY REGION

9.1.Overview

9.1.1.Market size and forecast, by region

9.2.North America

9.2.1.Key market trends, growth factors, and opportunities

9.2.2.Market size and forecast, by application

9.2.3.Market size and forecast, by component

9.2.4.Market size and forecast, by deployment model

9.2.5.Market size and forecast, by traditional end user

9.2.6.Market size and forecast, by type

9.2.7.Market size and forecast, by country

9.2.7.1.U.S.

9.2.7.1.1.Market size and forecast, by application

9.2.7.1.2.Market size and forecast, by component

9.2.7.1.3.Market size and forecast, by deployment model

9.2.7.1.4.Market size and forecast, by traditional end user

9.2.7.1.5.Market size and forecast, by type

9.2.7.2.CANADA

9.2.7.2.1.Market size and forecast, by application

9.2.7.2.2.Market size and forecast, by component

9.2.7.2.3.Market size and forecast, by deployment model

9.2.7.2.4.Market size and forecast, by traditional end user

9.2.7.2.5.Market size and forecast, by type

9.3.Europe

9.3.1.Key market trends, growth factors, and opportunities

9.3.2.Market size and forecast, by application

9.3.3.Market size and forecast, by component

9.3.4.Market size and forecast, by deployment model

9.3.5.Market size and forecast, by traditional end user

9.3.6.Market size and forecast, by type

9.3.7.Market size and forecast, by country

9.3.7.1.UK

9.3.7.1.1.Market size and forecast, by application

9.3.7.1.2.Market size and forecast, by component

9.3.7.1.3.Market size and forecast, by deployment model

9.3.7.1.4.Market size and forecast, by traditional end user

9.3.7.1.5.Market size and forecast, by type

9.3.7.2.GERMANY

9.3.7.2.1.Market size and forecast, by application

9.3.7.2.2.Market size and forecast, by component

9.3.7.2.3.Market size and forecast, by deployment model

9.3.7.2.4.Market size and forecast, by traditional end user

9.3.7.2.5.Market size and forecast, by type

9.3.7.3.FRANCE

9.3.7.3.1.Market size and forecast, by application

9.3.7.3.2.Market size and forecast, by component

9.3.7.3.3.Market size and forecast, by deployment model

9.3.7.3.4.Market size and forecast, by traditional end user

9.3.7.3.5.Market size and forecast, by type

9.3.7.4.ITALY

9.3.7.4.1.Market size and forecast, by application

9.3.7.4.2.Market size and forecast, by component

9.3.7.4.3.Market size and forecast, by deployment model

9.3.7.4.4.Market size and forecast, by traditional end user

9.3.7.4.5.Market size and forecast, by type

9.3.7.5.SPAIN

9.3.7.5.1.Market size and forecast, by application

9.3.7.5.2.Market size and forecast, by component

9.3.7.5.3.Market size and forecast, by deployment model

9.3.7.5.4.Market size and forecast, by traditional end user

9.3.7.5.5.Market size and forecast, by type

9.3.7.6.NETHERLANDS

9.3.7.6.1.Market size and forecast, by application

9.3.7.6.2.Market size and forecast, by component

9.3.7.6.3.Market size and forecast, by deployment model

9.3.7.6.4.Market size and forecast, by traditional end user

9.3.7.6.5.Market size and forecast, by type

9.3.7.7.REST OF EUROPE

9.3.7.7.1.Market size and forecast, by application

9.3.7.7.2.Market size and forecast, by component

9.3.7.7.3.Market size and forecast, by deployment model

9.3.7.7.4.Market size and forecast, by traditional end user

9.3.7.7.5.Market size and forecast, by type

9.4.Asia-Pacific

9.4.1.Key market trends, growth factors, and opportunities

9.4.2.Market size and forecast, by application

9.4.3.Market size and forecast, by component

9.4.4.Market size and forecast, by deployment model

9.4.5.Market size and forecast, by traditional end user

9.4.6.Market size and forecast, by type

9.4.7.Market size and forecast, by country

9.4.7.1.CHINA

9.4.7.1.1.Market size and forecast, by application

9.4.7.1.2.Market size and forecast, by component

9.4.7.1.3.Market size and forecast, by deployment model

9.4.7.1.4.Market size and forecast, by traditional end user

9.4.7.1.5.Market size and forecast, by type

9.4.7.2.JAPAN

9.4.7.2.1.Market size and forecast, by application

9.4.7.2.2.Market size and forecast, by component

9.4.7.2.3.Market size and forecast, by deployment model

9.4.7.2.4.Market size and forecast, by traditional end user

9.4.7.2.5.Market size and forecast, by type

9.4.7.3.SOUTH KOREA

9.4.7.3.1.Market size and forecast, by application

9.4.7.3.2.Market size and forecast, by component

9.4.7.3.3.Market size and forecast, by deployment model

9.4.7.3.4.Market size and forecast, by traditional end user

9.4.7.3.5.Market size and forecast, by type

9.4.7.4.AUSTRALIA

9.4.7.4.1.Market size and forecast, by application

9.4.7.4.2.Market size and forecast, by component

9.4.7.4.3.Market size and forecast, by deployment model

9.4.7.4.4.Market size and forecast, by traditional end user

9.4.7.4.5.Market size and forecast, by type

9.4.7.5.INDIA

9.4.7.5.1.Market size and forecast, by application

9.4.7.5.2.Market size and forecast, by component

9.4.7.5.3.Market size and forecast, by deployment model

9.4.7.5.4.Market size and forecast, by traditional end user

9.4.7.5.5.Market size and forecast, by type

9.4.7.6.REST OF ASIA-PACIFIC

9.4.7.6.1.Market size and forecast, by application

9.4.7.6.2.Market size and forecast, by component

9.4.7.6.3.Market size and forecast, by deployment model

9.4.7.6.4.Market size and forecast, by traditional end user

9.4.7.6.5.Market size and forecast, by type

9.5.LAMEA

9.5.1.Key market trends, growth factors, and opportunities

9.5.2.Market size and forecast, by application

9.5.3.Market size and forecast, by component

9.5.4.Market size and forecast, by deployment model

9.5.5.Market size and forecast, by traditional end user

9.5.6.Market size and forecast, by type

9.5.7.Market size and forecast, by country

9.5.7.1.LATIN AMERICA

9.5.7.1.1.Market size and forecast, by application

9.5.7.1.2.Market size and forecast, by component

9.5.7.1.3.Market size and forecast, by deployment model

9.5.7.1.4.Market size and forecast, by traditional end user

9.5.7.1.5.Market size and forecast, by type

9.5.7.2.MIDDLE EAST

9.5.7.2.1.Market size and forecast, by application

9.5.7.2.2.Market size and forecast, by component

9.5.7.2.3.Market size and forecast, by deployment model

9.5.7.2.4.Market size and forecast, by traditional end user

9.5.7.2.5.Market size and forecast, by type

9.5.7.3.AFRICA

9.5.7.3.1.Market size and forecast, by application

9.5.7.3.2.Market size and forecast, by component

9.5.7.3.3.Market size and forecast, by deployment model

9.5.7.3.4.Market size and forecast, by traditional end user

9.5.7.3.5.Market size and forecast, by type

CHAPTER 10:COMPETITIVE LANDSCAPE

10.1.Key players positioning analysis, 2020

10.2.Competitive dashboard

10.3.Top winning strategies

CHAPTER 11:COMPANY PROFILE

11.1.ALLSCRIPTS HEALTHCARE, LLC

11.1.1.Company overview

11.1.2.Key executives

11.1.3.Company snapshot

11.1.4.Operating business segments

11.1.5.Product portfolio

11.1.6.R&D expenditure

11.1.7.Business performance

11.1.8.Key strategic moves and developments

11.2.Cerner Corporation

11.2.1.Company overview

11.2.2.Key Executives

11.2.3.Company snapshot

11.2.4.Product portfolio

11.2.5.Business performance

11.2.6.Key strategic moves and developments

11.3.HEALTH CATALYST

11.3.1.Company overview

11.3.2.Key executives

11.3.3.Company snapshot

11.3.4.Operating business segments

11.3.5.Product portfolio

11.3.6.R&D expenditure

11.3.7.Business performance

11.3.8.Key strategic moves and developments

11.4.HMS(VITREOSHEALTH)

11.4.1.Company overview

11.4.2.Key executive

11.4.3.Company snapshot

11.4.4.Product portfolio

11.4.5.Business performance

11.5.INTERNATIONAL BUSINESS MACHINES CORPORATION

11.5.1.Company overview

11.5.2.Key executive

11.5.3.Company snapshot

11.5.4.Operating business segments

11.5.5.Product portfolio

11.5.6.R&D expenditure

11.5.7.Business performance

11.5.8.Key strategic moves and developments

11.6.MCKESSON CORPORATION

11.6.1.Company overview

11.6.2.Key executives

11.6.3.Company snapshot

11.6.4.Operating business segments

11.6.5.Product portfolio

11.6.6.R&D expenditure

11.6.7.Business performance

11.6.8.Key strategic moves and developments

11.7.MEDEANALYTICS, INC.

11.7.1.Company overview

11.7.2.Key executives

11.7.3.Company snapshot

11.7.4.Product portfolio

11.7.5.Key strategic moves and developments

11.8.OPTUM, INC.

11.8.1.Company overview

11.8.2.Key executives

11.8.3.Company snapshot

11.8.4.Product portfolio

11.9.ORACLE CORPORATION

11.9.1.Company overview

11.9.2.Key Executives

11.9.3.Company snapshot

11.9.4.Operating business segments

11.9.5.Product portfolio

11.9.6.R&D Expenditure

11.9.7.Business performance

11.9.8.Key strategic moves and developments

11.10.SAS INSTITUTE INC.

11.10.1.Company overview

11.10.2.Key executive

11.10.3.Company snapshot

11.10.4.Product portfolio

11.10.5.Key strategic moves and developments

TABLE 01.HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 02.HEALTHCARE ANALYTICS MARKET REVENUE FOR FINANCIAL ANALYSIS, BY REGION, 2020–2030 ($MILLION)

TABLE 03.HEALTHCARE ANALYTICS MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYSIS, BY REGION 2020–2030 ($MILLION)

TABLE 04.HEALTHCARE ANALYTICS MARKET FOR CLINICAL ANALYSIS, BY REGION 2020–2030 ($MILLION)

TABLE 05.HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 06.HEALTHCARE ANALYTICS MARKET REVENUE FOR HARDWARE, BY REGION, 2020–2030 ($MILLION)

TABLE 07.HEALTHCARE ANALYTICS MARKET FOR SOFTWARE, BY REGION 2020–2030 ($MILLION)

TABLE 08.HEALTHCARE ANALYTICS MARKET FOR SERVICE, BY REGION 2020–2030 ($MILLION)

TABLE 09.HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030($MILLION)

TABLE 10.HEALTHCARE ANALYTICS MARKET REVENUE FOR ON-PREMISE, BY REGION, 2020–2030 ($MILLION)

TABLE 11.HEALTHCARE ANALYTICS MARKET REVENUE FOR ON-DEMAND, BY REGION, 2020–2030 ($MILLION)

TABLE 12.HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030($MILLION)

TABLE 13.HEALTHCARE ANALYTICS MARKET REVENUE FOR HEALTHCARE PAYERS, BY REGION, 2020–2030 ($MILLION)

TABLE 14.HEALTHCARE ANALYTICS MARKET REVENUE FOR HEALTHCARE PROVIDERS, BY REGION, 2020–2030 ($MILLION)

TABLE 15.HEALTHCARE ANALYTICS MARKET REVENUE FOR OTHERS, BY REGION, 2020–2030 ($MILLION)

TABLE 16.HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030($MILLION)

TABLE 17.HEALTHCARE ANALYTICS MARKET REVENUE FOR DESCRIPTIVE ANALYTICS, BY REGION, 2020–2030 ($MILLION)

TABLE 18.HEALTHCARE ANALYTICS MARKET REVENUE FOR PREDICTIVE ANALYTICS, BY REGION, 2020–2030 ($MILLION)

TABLE 19.HEALTHCARE ANALYTICS MARKET REVENUE FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2020–2030 ($MILLION)

TABLE 20.HEALTHCARE ANALYTICS MARKET REVENUE, BY REGION, 2020–2030 ($MILLION)

TABLE 21.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 22.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 23.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 24.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 25.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 26.NORTH AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)

TABLE 27.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 28.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 29.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 30.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 31.U.S. HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 32.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 33.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 34.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 35.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 36.CANADA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 37.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 38.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 39.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 40.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 41.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 42.EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)

TABLE 43.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 44.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 45.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 46.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 47.UK HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 48.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 49.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 50.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 51.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 52.GERMANY HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 53.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 54.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 55.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 56.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 57.FRANCE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 58.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 59.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 60.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 61.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 62.ITALY HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 63.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 64.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 65.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 66.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 67.SPAIN HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 68.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 69.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 70.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 71.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 72.NETHERLANDS HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 73.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 74.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 75.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 76.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 77.REST OF EUROPE HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 78.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 79.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 80.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 81.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 82.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 83.ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)

TABLE 84.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 85.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 86.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 87.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 88.CHINA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 89.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 90.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 91.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 92.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 93.JAPAN HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 94.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 95.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 96.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 97.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 98.SOUTH KOREA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 99.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 100.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 101.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 102.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 103.AUSTRALIA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 104.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 105.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 106.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 107.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 108.INDIA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 109.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 110.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 111.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 112.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 113.REST OF ASIA-PACIFIC HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 114.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 115.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 116.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 117.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 118.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 119.LAMEA HEALTHCARE ANALYTICS MARKET REVENUE, BY COUNTRY, 2020–2028 ($MILLION)

TABLE 120.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 121.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 122.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 123.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 124.LATIN AMERICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 125.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 126.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 127.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 128.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 129.MIDDLE EAST HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 130.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 131.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY COMPONENT, 2020–2030 ($MILLION)

TABLE 132.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY DEPLOYMENT MODEL, 2020–2030 ($MILLION)

TABLE 133.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY END USER, 2020–2030 ($MILLION)

TABLE 134.AFRICA HEALTHCARE ANALYTICS MARKET REVENUE, BY TYPE, 2020–2030 ($MILLION)

TABLE 135.ALLSCRIPTS HEALTHCARE, LLC: KEY EXECUTIVE

TABLE 136.ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT

TABLE 137.ALLSCRIPTS HEALTHCARE, LLC: OPERATING SEGMENTS

TABLE 138.ALLSCRIPTS HEALTHCARE, LLC: PRODUCT PORTFOLIO

TABLE 139.CERNER CORPORATION: KEY EXECUTIVES

TABLE 140.CERNER CORPORATION: COMPANY SNAPSHOT

TABLE 141.CERNER CORPORATION: PRODUCT PORTFOLIO

TABLE 142.HEALTH CATALYST: KEY EXECUTIVE

TABLE 143.HEALTH CATALYST: COMPANY SNAPSHOT

TABLE 144.HEALTH CATALYST: OPERATING SEGMENTS

TABLE 145.HEALTH CATALYST: PRODUCT PORTFOLIO

TABLE 146.HMS(VITREOSHEALTH): KEY EXECUTIVE

TABLE 147.HMS(VITREOSHEALTH): COMPANY SNAPSHOT

TABLE 148.HMS(VITREOSHEALTH): PRODUCT PORTFOLIO

TABLE 149.INTERNATIONAL BUSINESS MACHINES CORPORATION: KEY EXECUTIVE

TABLE 150.INTERNATIONAL BUSINESS MACHINES CORPORATION: COMPANY SNAPSHOT

TABLE 151.INTERNATIONAL BUSINESS MACHINES CORPORATION: OPERATING SEGMENTS

TABLE 152.INTERNATIONAL BUSINESS MACHINES CORPORATION: PRODUCT PORTFOLIO

TABLE 153.MCKESSON CORPORATION.: KEY EXECUTIVES

TABLE 154.MCKESSON CORPORATION : COMPANY SNAPSHOT

TABLE 155.MCKESSON CORPORATION: OPERATING SEGMENTS

TABLE 156.MCKESSON CORPORATION: PRODUCT PORTFOLIO

TABLE 157.MEDEANALYTICS, INC.: KEY EXECUTIVES

TABLE 158.MEDEANALYTICS, INC.: COMPANY SNAPSHOT

TABLE 159.MEDEANALYTICS, INC.: PRODUCT PORTFOLIO

TABLE 160.OPTUM, INC.: KEY EXECUTIVES

TABLE 161.OPTUM, INC.: COMPANY SNAPSHOT

TABLE 162.OPTUM, INC.: PRODUCT PORTFOLIO

TABLE 163.ORACLE CORPORATION: KEY EXECUTIVES

TABLE 164.ORACLE CORPORATION: COMPANY SNAPSHOT

TABLE 165.ORACLE CORPORATION: OPERATING SEGMENTS

TABLE 166.ORACLE CORPORATION: PRODUCT PORTFOLIO

TABLE 167.ORACLE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS

TABLE 168.SAS INSTITUTE INC.: KEY EXECUTIVE

TABLE 169.SAS INSTITUTE INC.: COMPANY SNAPSHOT

TABLE 170.SAS INSTITUTE INC.: PRODUCT PORTFOLIO